Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review by William R. Short, Parul Patel, Gustavo Verdier, Ana Puga, Vani Vannappagari, Annemiek de Ruiter, Bryn Jones

Get full text

A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings by Cassidy Henegar, Emilio Letang, Ruolan Wang, Charles Hicks, Dainielle Fox, Bryn Jones, Annemiek de Ruiter, Vani Vannappagari

Get full text

Preferences for Starting Daily, On-Demand, and Long-Acting Injectable HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in the United States (2021-2022): Nationwide Onlin... by Duygu Islek, Travis Sanchez, Jennifer L Glick, Jeb Jones, Keith Rawlings, Supriya Sarkar, Patrick S Sullivan, Vani Vannappagari

Get full text

Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Co... by Lei Yan, Cassidy E. Henegar, Vincent C. Marconi, Kirsha S. Gordon, Charles Hicks, Vani Vannappagari, Amy C. Justice, Mihaela Aslan

Get full text

Antiretroviral therapy and liver disorders in the OPERA cohort by Michael Wohlfeiler, Karam Mounzer, Laurence Brunet, Jennifer Fusco, Vani Vannappagari, Lloyd Curtis, Nassrin Payvandi, Michael Aboud, Ricky Hsu, Philip Lackey, Gregory Fusco

Get full text

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes by Ricky K. Hsu, Jennifer S. Fusco, Cassidy E. Henegar, Vani Vannappagari, Andrew Clark, Laurence Brunet, Philip C. Lackey, Gerald Pierone, Gregory P. Fusco

Get full text

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study by Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone, Gregory P. Fusco

Get full text

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States by Gerald Pierone, Jennifer S. Fusco, Laurence Brunet, Vani Vannappagari, Supriya Sarkar, Cassidy E. Henegar, Jean van Wyk, Michael B. Wohlfeiler, Anthony Mills, Gregory P. Fusco

Get full text

Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis by Kim Anderson, Emma Kalk, Alexa Heekes, Florence Phelanyane, Nisha Jacob, Andrew Boulle, Ushma Mehta, Reshma Kassanjee, Gayathri Sridhar, Leigh Ragone, Vani Vannappagari, Mary‐Ann Davies

Get full text

Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment by John F P Bridges, Patrick S Sullivan, Vani Vannappagari, Sam Wilson Cole, Jennifer L Glick, Nicola B Campoamor, Travis H Sanchez, Supriya Sarkar, Alex Rinehart, Keith Rawlings

Get full text

Mother‐child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable? by Kim Anderson, Helena Rabie, Brian S. Eley, Lisa Frigati, James Nuttall, Emma Kalk, Alexa Heekes, Gayathri Sridhar, Leigh Ragone, Vani Vannappagari, Vanessa Mudaly, Andrew Boulle, Mary‐Ann Davies

Get full text

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort by Michael G. Sension, Laurence Brunet, Ricky K. Hsu, Jennifer S. Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B. Wohlfeiler, Gregory P. Fusco

Get full text

Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV by Vani Vannappagari, Scott McCallister, Beth Romach, Mark Bush, Dinesh Stanislaus, Charlotte Root, Christine Lampkin, Nneka Nwokolo, Ana Puga, Sebastian Moreira, Farzaneh Salem, Ralph DeMasi, Nassrin Payvandi, Kimberly Smith, Harmony Garges, Annemiek de Ruiter

Get full text

Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP by Jennifer L. Glick PhD, MPH, Danielle F. Nestadt PhD, MPH, MSW, Travis Sanchez DVM, MPH, Kevin Li MPH, Marissa Hannah MPH, M Keith Rawlings MD, Alex R. Rinehart PhD, Supriya Sarkar PhD, MPH, Vani Vannappagari PhD, MPH, MBBS

Get full text

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study by Annegret Pelchen-Matthews, Jakob Friis Larsen, Leah Shepherd, Josip Begovac, Karen Pedersen, Stéphane De Wit, Andrzej Horban, Elzbieta Jablonowska, Margaret Johnson, Irina Khromova, Marcelo H. Losso, Lars N. Nielsen, Anna Lisa Ridolfo, Brigitte Schmied, Christoph Stephan, Israel Yust, Lloyd Curtis, Vani Vannappagari, Leigh Ragone, Ashley Roen, Dorthe Raben, Ole Kirk, Lars Peters, Amanda Mocroft, for the EuroSIDA Study Group

Get full text

Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group. by Robin Schaefer, Logan Donaldson, Mitchell Leus, Chukwunomso E Osakwe, Benjamin Chimukangara, Shona Dalal, Ann Duerr, Fei Gao, David V Glidden, Beatriz Grinsztejn, Jessica Justman, Grace Kumwenda, Oliver Laeyendecker, Ha Youn Lee, Frank Maldarelli, Kenneth H Mayer, Jeffrey Murray, Bharat S Parekh, Brian Rice, Michael N Robertson, Suzue Saito, Vani Vannappagari, Mitchell Warren, Diana Zeballos, Jörg Zinserling, Veronica Miller

Get full text

Preference for Long-Acting Injectable PrEP Compared With Daily Oral PrEP Among Transgender Women in the U.S.: Findings From a Multisite Cohort by Erin E. Cooney, PhD, MSPH, Sari L. Reisner, ScD, MA, Tonia C. Poteat, PhD, MPH, PA-C, Asa E. Radix, MD, PhD, MPH, Kenneth H. Mayer, MD, Chris Beyrer, MD, MPH, Meg Stevenson, MSPH, Rodrigo A. Aguayo-Romero, PhD, Jason S. Schneider, MD, Andrew J. Wawrzyniak, PhD, Christopher M. Cannon, MPH, Carolyn A. Brown, PhD, MPH, Leigh Ragone, MS, Vani Vannappagari, PhD, Andrea L. Wirtz, PhD, MHS

Get full text

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium. by Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, Ferdinand Wit, Fiona Lampe, Huldrych F Günthard, Coca Necsoi, Matthew Law, Cristina Mussini, Antonella Castagna, Antonella d'Arminio Monforte, Christian Pradier, Nikoloz Chkhartisvilli, Juliana Reyes-Uruena, Jörg Janne Vehreschild, Jan-Christian Wasmuth, Anders Sönnerborg, Christoph Stephan, Lauren Greenberg, Josep M Llibre, Alain Volny-Anne, Lars Peters, Annegret Pelchen-Matthews, Vani Vannappagari, Joel Gallant, Armin Rieger, Mike Youle, Dominique Braun, Stephane De Wit, Kathy Petoumenos, Vanni Borghi, Vincenzo Spagnuolo, Tengiz Tsertsvadze, Jens Lundgren, Lene Ryom, RESPOND study group

Get full text

CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individua... by Cristina Mussini, Fiona Burns, Shema Tariq, Fiona M Burns, Caroline Sabin, Udi Davidovich, Bruno Spire, John Gill, Marc van der Valk, Linda Wittkop, Laurence Meyer, Kholoud Porter, Inés Suárez-García, Giota Touloumi, Lars Eriksson, Sophie Grabar, Santiago Moreno, Emily Jay Nicholls, Christina Carlander, Elisa Ruiz-Burga, Alain Volny Anne, Inma Jarrin, Nikos Pantazis, Rafael Eduardo Campo, Harmony Garges, Barbara Pinto, Vani Vannappagari, Alain Volny Anne, Lital Young, Marc van der Valk, Agnes Aisam, Diana Barger, Marie Dos Santos, Eli Fitzgerald, Argyro Karakosta, Hartmut Krentz, Nicoletta Policek, Chris Sandford

Get full text